Holen Sie sich die Stockscreener-App
57.64
0.78%
0.09
Spruce Biosciences Inc Aktie (SPRB) Neueste Nachrichten
SPRB Maintains by Citizens -- Price Target Lowered to $150 - GuruFocus
Spruce Biosciences price target lowered to $150 from $170 at Citizens - TipRanks
Citizens lowers Spruce Biosciences stock price target on model update - Investing.com
Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates - BioSpace
Spruce Biosciences (NASDAQ: SPRB) posts Q1 loss and bolsters cash - Stock Titan
Spruce Biosciences (SPRB) Progresses Towards Key Regulatory Mile - GuruFocus
Spruce Biosciences reports Q1 EPS ($8.94), consensus ($6.11) - TipRanks
Spruce Biosciences, Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Spruce Biosciences Reports Q1 2026 Financials, Advances TA-ERT Toward FDA Approval for MPS IIIB, and Strengthens Leadership Team - Minichart
Spruce Biosciences 1Q Research and Development Expenses $7.6M >SPRB - Moomoo
Spruce Biosciences reports Q1 2026 loss of $12.3M, cash $54.1M and $107.3M preliminary April balance - TradingView
Spruce Biosciences (SPRB) boosts cash with $69M raise, funds TA‑ERT into 2027 - Stock Titan
TradingKey - TradingKey
Ikarian Capital, Neil Shahrestani file ownership of 121,356 SPRB shares (4.8%) - Stock Titan
SPRB Stock Price, Quote & Chart | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill
Spruce Biosciences appoints two commercial executives By Investing.com - Investing.com Australia
Spruce Biosciences Expands Leadership Team - Contract Pharma
Spruce Biosciences Adds Two Senior Commercial Executives as It Prepares Rare Disease Launch Strategy - citybiz
Spruce Biosciences appoints two commercial executives - Investing.com
Spruce Biosciences further strengthens its commercial leadership team with the appointments of Brian Walls as vice president, market access and Darren Johnson as vice president, commercial operations - marketscreener.com
Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations - ChartMill
Wall Street Analysts Believe Spruce Biosciences (SPRB) Could Rally 181.21%: Here's is How to Trade - MSN
SPRB Technical Analysis | Trend, Signals & Chart Patterns | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill
ExodusPoint entities file Schedule 13G on SPRB (SPRB) - Stock Titan
Spruce Biosciences (SPRB) Projected to Post Earnings on Tuesday - MarketBeat
SPRB Initiated Coverage by Craig-Hallum -- Rating Set to Buy - GuruFocus
Craig-Hallum initiates Spruce Biosciences stock with buy rating By Investing.com - Investing.com South Africa
Craig-Hallum initiates Spruce Biosciences stock with buy rating - Investing.com
Craig Hallum Initiates Coverage on Spruce Biosciences (NASDAQ:SPRB) - MarketBeat
Craig-Hallum Initiates Spruce Biosciences(SPRB.US) With Buy Rating, Announces Target Price $140 - Moomoo
Spruce Biosciences announces proposed public offering of common stock, pre-funded warrants - MSN
Spruce Biosciences to enact 1-for-75 reverse stock split - MSN
Spruce Biosciences Prices Equity Offering to Raise Capital - The Globe and Mail
SPRB (Spruce Biosciences Inc.) posts wider than expected Q4 2025 EPS loss yet shares edge higher.Share Dilution - Cổng thông tin điện tử Tỉnh Sơn La
SPRB Spruce Biosciences reports wider than expected Q4 2025 loss, shares drop 2.32% amid investor concern. - Cổng thông tin điện tử tỉnh Lào Cai
SPRB Spruce Biosciences Inc. gains 3.53 percent even as Q4 2025 earnings miss analyst consensus estimates.Recovery Report - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Wednesday's Pre-Market SessionAxe Compute (NASDAQ:AGPU), Alpha Compute - Benzinga
Spruce Biosciences Enters Underwriting For $69 Million Equity Offering; Option Fully Exercised - TradingView
Spruce Biosciences prices $60M public offering at $50.00 per share - MSN
Spruce Biosciences (NASDAQ: SPRB) raises about $69.0 million in equity sale - Stock Titan
Spruce Biosciences (NASDAQ: SPRB) sells 1.15M shares, issues pre-funded warrants - Stock Titan
Why is Spruce Biosciences stock sinking Tuesday? - MSN
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Spruce Biosciences (SPRB) and AXT (AXTI) Stocks Decline Followin - GuruFocus
SPRB: New Offering Managed by Leading Investment Firms - GuruFocus
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Is Spruce Biosciences Stock Sinking Tuesday? - Benzinga
Morning Market Movers: LOCL, CLIK, SPRC, SPRB See Big Swings - RTTNews
0.75%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):